Cargando…

Lipid nanomaterials-based RNA therapy and cancer treatment

We summarize the most important advances in RNA delivery and nanomedicine. We describe lipid nanoparticle-based RNA therapeutics and the impacts on the development of novel drugs. The fundamental properties of the key RNA members are described. We introduced recent advances in the nanoparticles to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xingcai, Hai, Luo, Gao, Yibo, Yu, Guocan, Sun, Yingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031258/
https://www.ncbi.nlm.nih.gov/pubmed/36970213
http://dx.doi.org/10.1016/j.apsb.2022.10.004
_version_ 1784910566912950272
author Zhang, Xingcai
Hai, Luo
Gao, Yibo
Yu, Guocan
Sun, Yingli
author_facet Zhang, Xingcai
Hai, Luo
Gao, Yibo
Yu, Guocan
Sun, Yingli
author_sort Zhang, Xingcai
collection PubMed
description We summarize the most important advances in RNA delivery and nanomedicine. We describe lipid nanoparticle-based RNA therapeutics and the impacts on the development of novel drugs. The fundamental properties of the key RNA members are described. We introduced recent advances in the nanoparticles to deliver RNA to defined targets, with a focus on lipid nanoparticles (LNPs). We review recent advances in biomedical therapy based on RNA drug delivery and state-of-the-art RNA application platforms, including the treatment of different types of cancer. This review presents an overview of current LNPs based RNA therapies in cancer treatment and provides deep insight into the development of future nanomedicines sophisticatedly combining the unparalleled functions of RNA therapeutics and nanotechnology.
format Online
Article
Text
id pubmed-10031258
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-100312582023-03-23 Lipid nanomaterials-based RNA therapy and cancer treatment Zhang, Xingcai Hai, Luo Gao, Yibo Yu, Guocan Sun, Yingli Acta Pharm Sin B Review We summarize the most important advances in RNA delivery and nanomedicine. We describe lipid nanoparticle-based RNA therapeutics and the impacts on the development of novel drugs. The fundamental properties of the key RNA members are described. We introduced recent advances in the nanoparticles to deliver RNA to defined targets, with a focus on lipid nanoparticles (LNPs). We review recent advances in biomedical therapy based on RNA drug delivery and state-of-the-art RNA application platforms, including the treatment of different types of cancer. This review presents an overview of current LNPs based RNA therapies in cancer treatment and provides deep insight into the development of future nanomedicines sophisticatedly combining the unparalleled functions of RNA therapeutics and nanotechnology. Elsevier 2023-03 2022-10-11 /pmc/articles/PMC10031258/ /pubmed/36970213 http://dx.doi.org/10.1016/j.apsb.2022.10.004 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Zhang, Xingcai
Hai, Luo
Gao, Yibo
Yu, Guocan
Sun, Yingli
Lipid nanomaterials-based RNA therapy and cancer treatment
title Lipid nanomaterials-based RNA therapy and cancer treatment
title_full Lipid nanomaterials-based RNA therapy and cancer treatment
title_fullStr Lipid nanomaterials-based RNA therapy and cancer treatment
title_full_unstemmed Lipid nanomaterials-based RNA therapy and cancer treatment
title_short Lipid nanomaterials-based RNA therapy and cancer treatment
title_sort lipid nanomaterials-based rna therapy and cancer treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031258/
https://www.ncbi.nlm.nih.gov/pubmed/36970213
http://dx.doi.org/10.1016/j.apsb.2022.10.004
work_keys_str_mv AT zhangxingcai lipidnanomaterialsbasedrnatherapyandcancertreatment
AT hailuo lipidnanomaterialsbasedrnatherapyandcancertreatment
AT gaoyibo lipidnanomaterialsbasedrnatherapyandcancertreatment
AT yuguocan lipidnanomaterialsbasedrnatherapyandcancertreatment
AT sunyingli lipidnanomaterialsbasedrnatherapyandcancertreatment